TELIX PHARMACEUTICALS LIMITEDTELIX PHARMACEUTICALS LIMITEDTELIX PHARMACEUTICALS LIMITED

TELIX PHARMACEUTICALS LIMITED

No trades
See on Supercharts

Price target

26.010.000.00%
The 7 analysts offering 1 year price forecasts for TLX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to TLX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TLX EPS for the last quarter is 0.09 AUD despite the estimation of 0.14 AUD. In the next quarter EPS is expected to reach 0.09 AUD. Track more of TELIX PHARMACEUTICALS LIMITED financials and stay on top of what is up with the company.
In the next quarter TELIX PHARMACEUTICALS LIMITED revenue is expected to reach ‪401.18 M‬ AUD. Check out TELIX PHARMACEUTICALS LIMITED revenue and earnings and make informed decisions.
According to analysts, TLX price target is 26.01 AUD with a max estimate of 33.40 AUD and a min estimate of 21.60 AUD. Check if this forecast comes true in a year, meanwhile watch TELIX PHARMACEUTICALS LIMITED stock price chart and keep track of the current situation with TLX news and stock market news.
We've gathered opinions of 10 analysts rating TLX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.